Plasma homocysteine, methylene tetrahydrofolate reductase C677T and factor II G20210A polymorphisms, factor VIII, and VWF in central retinal vein occlusion

AIMS To determine whether plasma homocysteine, methylene tetrahydrofolate reductase (MTHFR) C677T and factor II G20210A polymorphisms, factor VIII, and vWF are risk factors for central retinal vein occlusion (CRVO). METHOD Prospective comparison of 63 consecutive patients with central retinal vein o...

Ausführliche Beschreibung

Gespeichert in:

Bibliographische Detailangaben
Veröffentlicht in:	British journal of ophthalmology 2001-11, Vol.85 (11), p.1313-1315
Hauptverfasser:	Boyd, S, Owens, D, Gin, T, Bunce, K, Sherafat, H, Perry, D, Hykin, P G
Format:	Artikel
Sprache:	eng
Schlagworte:	Biological and medical sciences Blood Coagulation - physiology Case-Control Studies central retinal vein occlusion Enzyme-Linked Immunosorbent Assay Evaluation factor II factor VIII Factor VIII - analysis Health risk assessment Homocysteine Homocysteine - blood Humans hyperhomocysteinaemia Logistic Models Medical sciences Methylenetetrahydrofolate Dehydrogenase (NADP) - genetics Middle Aged Mutation Mutation - genetics Ophthalmology Plasma Polymerase Chain Reaction Polymorphism, Genetic Prospective Studies Prothrombin - genetics Retinal diseases Retinal Vein Occlusion - blood Retinal Vein Occlusion - genetics Retinopathies Risk factors Scientific Correspondence Veins & arteries von Willebrand factor von Willebrand Factor - analysis
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!

Schreiben Sie den ersten Kommentar!